| Specialty Retail Industry | Consumer Discretionary Sector | Michael Hill CEO | OTC PINK Exchange | 094857109 CUSIP |
| US Country | 23 Employees | - Last Dividend | 11 Dec 2006 Last Split | - IPO Date |
Bloomios, Inc. is a prominent player in the burgeoning cannabidiol (CBD) industry, focusing on the manufacture, marketing, and distribution of a wide variety of CBD products. Originally founded in 2001 as XLR Medical Corp., the company underwent a significant rebranding in April 2021 and adopted its current name to better reflect its specialized focus and market position. Headquartered in Santa Barbara, California, Bloomios has carved out a niche for itself by offering an extensive range of hemp-derived supplements and cosmetic products. The company utilizes both wholesale and retail distribution channels to reach its consumer base, ensuring a broad and accessible market presence for its diverse product offerings.
Bloomios, Inc. provides a comprehensive assortment of cannabidiol products, catering to a variety of consumer needs and preferences. Each product category is designed to harness the therapeutic potential of CBD, with options available for both human and pet use. Below is a brief overview of their main product categories: